Health Care • Medical/Dental Instruments
$24.71 ▲ +1.20
(+5.10%)
MKT CAP: $3.78B • VOL: 4.04M
52W L $19 52W H $30
NVST // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>)
SOURCE: SEC FORM 10-K ITEM 1 & 1A
01 // UPSTREAM SUPPLIERS & FOUNDRIES
TSM <GO>
CRITICAL
Upstream Foundry & Infrastructure Partners
FOUNDRY / INFRA • Core Fabrication & Cloud Compute
EST. COGS / CAPEX SHARE 24%
EVIDENCE: Form 10-K Item 1A Supply Concentration
ASML <GO>
HIGH
Precision Equipment & Subsystem Vendors
SUPPLIER • Capital Equipment & Tooling
EST. COGS / CAPEX SHARE 14%
EVIDENCE: Form 10-K Note 12 Purchase Commitments
CORE VALUE-CHAIN HUB NYSE
NVST // Envista Holdings Corporation
GROSS MARGIN
54.7%
OP MARGIN
7.9%
ROIC %
5.1%
MKT CAP
$3.78B
UPSTREAM INPUTS ──► NVST OPERATING ENGINE ──► CUSTOMER REVENUE
03 // DOWNSTREAM REVENUE CUSTOMERS
MSFT <GO>
REV SHARE: ~19%
Hyperscale & Enterprise Cloud Accounts
CUSTOMER • Enterprise Infrastructure
EVIDENCE: Form 10-K Segment & Major Customer Footnote
AMZN <GO>
REV SHARE: ~13%
Global Commercial & Distribution Channels
CUSTOMER • Commercial Distribution
EVIDENCE: Form 10-K Geographic & Channel Breakdown
DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX
LIVE DB CROSS-COMPARISON
| TICKER | COMPANY | LAST | MKT CAP | GROSS MGN | OP MGN | ROIC % | EV/EBITDA | REV YOY | HEAD-TO-HEAD |
|---|---|---|---|---|---|---|---|---|---|
| NVST ★ | Envista Holdings Corporation | $24.71 | $3.78B | 54.7% | 7.9% | 5.1% | 16.5x | +8.3% | SUBJECT ISSUER |
| LLY | Eli Lilly and Company | $1,417.54 | $1.33T | 83.6% | 40.2% | 32.4% | 36.4x | +45.5% | NVST VS LLY <GO> |
| JNJ | Johnson & Johnson | $273.20 | $657.68B | 67.9% | 34.7% | 25.5% | 18.5x | +6.0% | NVST VS JNJ <GO> |
| ABBV | AbbVie Inc. | $294.89 | $521.11B | 70.2% | 24.6% | 29.0% | 33.3x | +8.6% | NVST VS ABBV <GO> |
| MRK | Merck & Company Inc. | $149.52 | $368.89B | 74.8% | 34.3% | 20.7% | 15.3x | +1.3% | NVST VS MRK <GO> |
| UNH | UnitedHealth Group Incorporated | $406.97 | $365.29B | 88.6% | 4.8% | 11.5% | 16.5x | +6.5% | NVST VS UNH <GO> |